Cost-Effectiveness of Vedolizumab for the Treatment of Adult Patients with Moderately-to-Severely Active Ulcerative Colitis in Russia
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1438
https://www.valueinhealthjournal.com/article/S1098-3015(17)31772-2/fulltext
Title :
Cost-Effectiveness of Vedolizumab for the Treatment of Adult Patients with Moderately-to-Severely Active Ulcerative Colitis in Russia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31772-2&doi=10.1016/j.jval.2017.08.1438
First page :
A635
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1281